Director, HTA Value and Evidence
Pfizer Inc.
Disclosure(s): Pfizer Inc: Employer, Stocks/Bonds (Public Company)
Dr. Yehoshua works as Director of mRNA HTA Value and Evidence at Pfizer. He has over 12 years of Health Economics and Outcomes Research / Real World Evidence (HEOR/RWE) experience including database analysis, and over 3 years of experience conducting research in infectious diseases. Other therapeutics areas of research include urology, neurology, nephrology, bone, inflammation, and liver disease. He has led numerous HEOR/RWE activities and HTA submissions for products globally, with a strong focus on the US.